Pfizer Beats UPC Infringement Claim Over COVID Treatment
Pfizer has defeated a claim that its COVID-19 treatment infringes a rival's patent in Europe, convincing the Unified Patent Court that its opponent's patent was never valid in the first place....To view the full article, register now.
Already a subscriber? Click here to view full article